Intra-Cellular drug fails bipolar depression study; shares fall 14%

Intra-Cellular Therapies Inc said on Monday its lead drug failed to meet the main goal of a late-stage study in patients with major depressive episodes associated with bipolar disorder.

Source: Reuters: Health - July 8, 2019 Category: Consumer Health News Tags: healthNews Source Type: news